Senti Biosciences, Inc.
SNTI
$2.08
-$0.02-0.95%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -47.58M | -58.32M | -54.79M | -52.79M | -70.90M |
| Total Depreciation and Amortization | 4.20M | 4.25M | 4.30M | 4.36M | 4.38M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -8.57M | 6.35M | 3.75M | 1.41M | 18.53M |
| Change in Net Operating Assets | 1.88M | -764.00K | 2.97M | 5.63M | 13.07M |
| Cash from Operations | -50.07M | -48.49M | -43.77M | -41.40M | -34.93M |
| Capital Expenditure | -207.00K | -207.00K | -11.00K | -26.00K | -19.00K |
| Sale of Property, Plant, and Equipment | 12.00K | 72.00K | 60.00K | 60.00K | 165.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -195.00K | -135.00K | 49.00K | 34.00K | 146.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -23.00K |
| Issuance of Common Stock | 49.72M | 49.59M | 49.06M | 49.06M | 589.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.29M | 4.73M | 4.26M | 4.67M | 2.43M |
| Cash from Financing | 52.01M | 54.33M | 53.32M | 53.73M | 3.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.74M | 5.70M | 9.60M | 12.37M | -31.79M |